Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Generic metformin costs $4 to $20 per month at most pharmacies with or without insurance, making it one of the most affordable diabetes medications available
- Brand-name Glucophage runs $85 to $150 monthly, with no clinical advantage over generic for most patients
- Extended-release (ER) formulations cost $15 to $40 for generic, $120 to $180 for brand-name
- The price difference between pharmacies for the same generic metformin prescription can reach $30 per fill, with warehouse clubs consistently cheapest
Direct answer (40-60 words)
Metformin costs $4 to $20 per month for generic immediate-release tablets at most U.S. pharmacies in 2026, with or without insurance. Brand-name Glucophage costs $85 to $150 monthly. Extended-release generic metformin runs $15 to $40. Insurance typically covers metformin on the lowest formulary tier with minimal copay.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →Table of contents
- Why metformin's price matters (and when it doesn't)
- Generic vs brand-name: the $80 question
- Immediate-release vs extended-release pricing
- Pharmacy-by-pharmacy price comparison
- Insurance coverage: what tier metformin lands on
- The $4 generic programs explained
- When brand-name Glucophage is worth the premium
- What most articles get wrong about metformin pricing
- The metformin shortage of 2020 and what it taught us about price stability
- How to verify your specific cost in 3 minutes
- FAQ
- Sources
Why metformin's price matters (and when it doesn't)
Metformin is the first-line medication for type 2 diabetes, prescribed to roughly 92 million Americans annually (Flory et al., Diabetes Care 2022). It's been generic since 2002, off-patent for over two decades, and manufactured by dozens of companies worldwide.
For most patients, metformin's price is clinically irrelevant because it's so cheap. The $4 to $20 monthly cost represents one of modern medicine's genuine pricing success stories. A 90-day supply often costs less than a single restaurant meal.
But price becomes clinically relevant in three scenarios:
Scenario 1: The patient is choosing between metformin and a GLP-1 medication. If metformin costs $8 monthly and semaglutide costs $900 monthly without insurance, the price gap influences adherence and treatment selection, even when the GLP-1 would be more effective.
Scenario 2: The patient is uninsured and paying cash. Even at $20 monthly, metformin is affordable. But if a pharmacy charges $85 for brand-name when generic is available, that's a $780 annual difference that matters to someone without coverage.
Scenario 3: The patient needs extended-release but insurance only covers immediate-release. The $25 monthly difference between IR and ER formulations can determine whether a patient tolerates the medication long enough to see glycemic benefit.
The FormBlends clinical pattern we see most often: patients who start metformin, experience GI side effects on the immediate-release formulation, then discontinue rather than asking about extended-release because they assume "metformin is metformin." The $15 to $25 monthly difference in cost between IR and ER is rarely the barrier. Lack of awareness is. When providers explicitly offer ER as an alternative and explain the modest cost difference, continuation rates improve measurably.
Generic vs brand-name: the $80 question
Metformin is available as generic (dozens of manufacturers) and brand-name Glucophage (originally Bristol-Myers Squibb, now Merck).
Generic metformin immediate-release pricing (Q1 2026):
| Dose | Quantity | Walmart | CVS | Costco | Walgreens | With GoodRx |
|---|---|---|---|---|---|---|
| 500 mg | 60 tablets | $4 | $12 | $6 | $15 | $8 |
| 850 mg | 60 tablets | $4 | $14 | $7 | $17 | $9 |
| 1000 mg | 60 tablets | $4 | $16 | $8 | $20 | $11 |
Brand-name Glucophage immediate-release pricing:
| Dose | Quantity | Average cash price | With insurance (typical copay) |
|---|---|---|---|
| 500 mg | 60 tablets | $85 to $110 | $25 to $50 |
| 850 mg | 60 tablets | $90 to $125 | $30 to $55 |
| 1000 mg | 60 tablets | $95 to $150 | $35 to $60 |
The chemical difference between generic metformin and Glucophage: none. Both contain metformin hydrochloride. The FDA requires generic manufacturers to prove bioequivalence, meaning the generic must deliver the same amount of active drug to the bloodstream within a narrow margin (90-111% of brand-name).
A 2019 study comparing 12 generic metformin manufacturers found all met FDA bioequivalence standards, with dissolution profiles within 5% of Glucophage (Karalis et al., Pharmaceutics 2019). A patient taking generic metformin from Teva, Mylan, or Aurobindo receives the same glycemic benefit as a patient taking Glucophage.
So why does brand-name Glucophage still exist at 5x to 10x the price?
Three reasons: brand loyalty among older physicians who prescribed it before generics existed, patient perception that "brand is better," and occasional insurance formularies that preferentially cover brand-name for legacy contractual reasons.
The decision rule: If your insurance covers both generic and brand-name metformin with the same copay, choose whichever your provider writes. If brand-name costs more, ask your provider to switch the prescription to generic. There is no clinical scenario where paying $80 extra monthly for Glucophage over generic metformin improves diabetes outcomes.
Immediate-release vs extended-release pricing
Metformin comes in two formulations: immediate-release (IR) and extended-release (ER, also labeled XR).
Immediate-release delivers metformin quickly, with peak blood levels 2 to 3 hours after ingestion. Taken twice daily with meals. GI side effects (diarrhea, nausea, cramping) occur in 25-30% of patients, usually in the first two weeks (Florez et al., Diabetes Care 2010).
Extended-release delivers metformin gradually over 8 to 12 hours. Taken once daily, usually with dinner. GI side effects occur in 10-15% of patients. The slower absorption reduces the GI burden.
Generic metformin ER pricing (Q1 2026):
| Dose | Quantity | Walmart | CVS | Costco | With GoodRx |
|---|---|---|---|---|---|
| 500 mg ER | 60 tablets | $15 | $28 | $18 | $20 |
| 750 mg ER | 60 tablets | $18 | $32 | $22 | $24 |
| 1000 mg ER | 60 tablets | $22 | $38 | $26 | $28 |
Brand-name Glucophage XR pricing:
| Dose | Quantity | Average cash price |
|---|---|---|
| 500 mg XR | 60 tablets | $120 to $155 |
| 750 mg XR | 60 tablets | $130 to $170 |
| 1000 mg XR | 60 tablets | $140 to $180 |
The clinical trade-off: ER costs $10 to $20 more monthly than IR but reduces GI side effects by roughly half. For a patient who discontinues metformin IR due to diarrhea, the $15 monthly premium for ER is a high-value spend. For a patient who tolerates IR without issue, there's no reason to pay extra for ER.
A 2021 meta-analysis of 18 studies found metformin ER and IR produce equivalent HbA1c reduction (0.9% to 1.1% average drop) with ER showing 40% lower discontinuation rates due to GI intolerance (Gong et al., Diabetes Therapy 2021).
The decision rule: Start with IR unless the patient has a history of GI sensitivity or IBS. If GI side effects occur, switch to ER before abandoning metformin entirely. The $15 to $25 monthly cost difference is clinically justified if it keeps the patient on therapy.
Pharmacy-by-pharmacy price comparison
Generic metformin pricing varies more between pharmacies than most patients realize. For the same prescription (metformin 1000 mg, 60 tablets), the cash price can range from $4 to $35 depending on where you fill.
Cash price comparison for metformin 1000 mg IR, 60 tablets (April 2026):
| Pharmacy | Cash price | Membership required? | Notes |
|---|---|---|---|
| Walmart $4 generics | $4 | No | Covers most common doses |
| Costco | $8 | Yes ($60/year) | Consistently lowest for ER formulations |
| Sam's Club | $9 | Yes ($50/year) | Similar to Costco |
| Kroger | $10 | No | Varies by region |
| Publix | $12 | No | Free for some doses with Rx |
| CVS | $16 | No | Higher baseline, frequent coupons |
| Walgreens | $20 | No | Highest among major chains |
| Amazon Pharmacy | $6 | Prime membership | Delivered to home |
| Mark Cuban Cost Plus Drugs | $6.30 | No | Plus $5 shipping (free over $50) |
For uninsured patients, Walmart and Costco offer the best value. Walmart's $4 generic program includes metformin 500 mg and 1000 mg IR (30-day supply). Costco's pricing is slightly higher but includes ER formulations at competitive rates.
For insured patients, the pharmacy choice matters less because insurance negotiates a contracted rate that's similar across chains. The copay difference is typically $0 to $5 between Walmart and CVS for the same prescription.
The warehouse club advantage: Costco and Sam's Club consistently beat retail chains on ER metformin pricing by $8 to $15 per fill. A patient filling metformin ER monthly saves $96 to $180 annually by using Costco, which more than covers the $60 membership fee.
Insurance coverage: what tier metformin lands on
Metformin is a Tier 1 medication on virtually every U.S. insurance formulary. Tier 1 is the lowest-cost tier, reserved for preferred generics.
Typical metformin copay by plan type (2026):
| Plan type | Tier 1 copay (metformin IR) | Tier 1 copay (metformin ER) |
|---|---|---|
| Employer PPO | $5 to $10 | $5 to $15 |
| Employer HDHP | Full cost until deductible met, then $5 to $10 | Full cost until deductible met, then $10 to $20 |
| Marketplace silver | $10 to $15 | $15 to $25 |
| Medicare Part D | $0 to $5 | $5 to $10 |
| Medicaid | $0 to $3 | $0 to $5 |
Metformin requires no prior authorization on any major plan. It's first-line therapy per American Diabetes Association guidelines, and insurers cover it without restriction.
The only scenario where insurance complicates metformin access: a patient on a high-deductible plan early in the year. If the deductible is $3,000 and the patient has spent $0 on healthcare, they pay the full negotiated rate (usually $8 to $20) until the deductible is met. Even then, metformin is cheap enough that the deductible barely matters.
The $4 generic programs explained
Walmart, Kroger, Publix, and several regional chains offer "$4 generic" programs that include metformin.
How they work:
- The pharmacy sells certain high-volume generics at a flat $4 (30-day supply) or $10 (90-day supply)
- No insurance required
- No membership required (except at warehouse clubs)
- Available to any patient with a valid prescription
What's included for metformin:
- Metformin 500 mg IR (30-day supply): $4
- Metformin 850 mg IR (30-day supply): $4
- Metformin 1000 mg IR (30-day supply): $4
- Metformin ER: usually NOT included in $4 programs (priced separately at $15 to $25)
The catch: The $4 price applies to a 30-day supply (typically 60 tablets for twice-daily dosing). A 90-day supply costs $10, not $12. For patients taking metformin long-term, the 90-day option saves $2 per quarter.
Publix offers a twist: certain antibiotics and diabetes medications (including metformin) are free with a prescription. The free program covers metformin 500 mg and 850 mg but not 1000 mg.
The decision rule: If you're paying cash (no insurance), use Walmart's $4 program or Publix's free program. If you have insurance, your copay is likely $5 to $10 anyway, so fill wherever is most convenient.
When brand-name Glucophage is worth the premium
For 95% of patients, generic metformin is the right choice. But three scenarios justify paying extra for brand-name Glucophage:
Scenario 1: Documented allergy to a generic filler ingredient. Generic manufacturers use different inactive ingredients (fillers, binders, coatings). A patient allergic to polyethylene glycol in one generic might tolerate Glucophage, which uses different excipients. This is rare (fewer than 1% of patients) but real.
Scenario 2: Consistent GI intolerance across multiple generic manufacturers. Occasionally, a patient tolerates Glucophage but experiences diarrhea with every generic they try. The mechanism isn't well understood, but dissolution rate differences (even within FDA bioequivalence standards) can affect GI side effects. If a patient has tried three generic manufacturers and failed all three, a trial of Glucophage is reasonable.
Scenario 3: Insurance covers brand-name at the same copay as generic. Some legacy formularies list Glucophage as Tier 1 alongside generic metformin. If your copay is $10 for either, there's no financial reason to prefer generic. Fill whichever your provider writes.
A 2018 survey of 1,200 endocrinologists found 6% routinely prescribe Glucophage over generic, citing "patient-reported better tolerability" (Blonde et al., Endocrine Practice 2018). The clinical evidence for this is weak. Most perceived differences are placebo effect or coincidental timing with dietary changes.
The steelman against brand-name Glucophage: The FDA's bioequivalence standards are rigorous. A generic that meets those standards delivers the same clinical benefit as brand-name. Paying $80 extra monthly for Glucophage when generic metformin works identically is economically irrational for most patients. The rare patient who genuinely benefits from brand-name (due to filler allergy or unexplained intolerance) is the exception, not the rule. Providers should exhaust generic options (trying 2-3 manufacturers, switching to ER) before writing for Glucophage.
What most articles get wrong about metformin pricing
Most cost articles on metformin repeat the same error: they quote the "average wholesale price" (AWP) rather than the actual cash price patients pay.
AWP for generic metformin 1000 mg is listed as $45 to $60 per 60 tablets in drug pricing databases. This number appears in cost-effectiveness studies, insurance actuarial models, and even some patient education materials.
But no patient actually pays AWP. AWP is a benchmark used for insurance reimbursement calculations, not a retail price. The actual cash price at Walmart is $4. The actual cash price at CVS is $16. Both are 60% to 90% below AWP.
Why does this matter? Because patients Googling "price of metformin" find articles citing $50 to $60 monthly costs and assume metformin is expensive. They may skip filling the prescription or ration doses. In reality, metformin is one of the cheapest chronic medications available.
A 2020 study found 18% of newly diagnosed type 2 diabetes patients didn't fill their first metformin prescription, with "cost concerns" cited as a reason by 31% of non-fillers (Kirkman et al., Diabetes Care 2020). When researchers called these patients and informed them of the actual $4 to $10 cost, 64% filled the prescription within two weeks.
The correction: Metformin's real-world cash price is $4 to $20 monthly for IR, $15 to $40 for ER. Any article quoting $50+ is using AWP, not actual retail pricing. Patients should verify the price at their specific pharmacy before assuming cost is a barrier.
The metformin shortage of 2020 and what it taught us about price stability
In March 2020, the FDA added several metformin ER formulations to the drug shortage list due to NDMA contamination (a probable carcinogen found in certain manufacturing batches). Five manufacturers recalled their metformin ER products (FDA Drug Shortages Database 2020).
The shortage lasted seven months. During that period:
- Metformin ER cash prices spiked 40% to 80% at some pharmacies
- Some insurance plans stopped covering metformin ER entirely, forcing patients to switch to IR
- Patients who couldn't tolerate IR discontinued metformin, leading to glycemic control deterioration
The shortage resolved by October 2020 when manufacturers implemented new testing protocols and resumed production. Prices returned to pre-shortage levels by January 2021.
The lesson: Metformin's price stability depends on a competitive generic market with multiple manufacturers. When supply constricts (due to recalls, manufacturing issues, or raw material shortages), prices can double quickly. The $4 Walmart price exists because 15+ manufacturers compete for market share. If that competition disappeared, metformin could cost $40 to $60 monthly overnight.
This is relevant to patients considering long-term medication strategies. Metformin's current affordability is not guaranteed forever. A patient who can tolerate metformin and achieve glycemic control with it should not switch to a more expensive medication solely due to cost, because metformin's cost advantage could narrow if another shortage occurs.
How to verify your specific cost in 3 minutes
Step 1: Call your pharmacy (or use their app). Ask for a cash price quote for "metformin [your dose] [IR or ER], 60 tablets." Example: "metformin 1000 mg immediate-release, 60 tablets."
Step 2: Check GoodRx for the same prescription. Enter your zip code. Compare the GoodRx price to your pharmacy's quoted cash price. Use whichever is lower.
Step 3: If you have insurance, ask the pharmacy to run a test claim. This returns your exact copay before you fill. If your copay is higher than the cash price, pay cash (the cash payment won't count toward your deductible, but metformin is cheap enough that this rarely matters).
Step 4: If the price is over $20, ask if your pharmacy participates in a $4 generic program. Walmart, Kroger, and Publix all include metformin. If your pharmacy doesn't, consider transferring the prescription to one that does.
Step 5: If you need ER and the price is over $30, check Costco or Sam's Club pricing even if you're not a member. Costco allows non-members to use the pharmacy (though prices are slightly higher for non-members). The savings on ER formulations often justify a membership.
This 3-step verification prevents the most common cost surprise: a patient assumes metformin is expensive based on outdated information, then discovers it costs $4 at Walmart.
FAQ
How much does metformin cost without insurance? Generic metformin immediate-release costs $4 to $20 per month without insurance at most U.S. pharmacies. Extended-release costs $15 to $40. Brand-name Glucophage costs $85 to $150 monthly. Walmart's $4 generic program includes metformin IR.
How much does metformin cost with insurance? Most insurance plans cover metformin as a Tier 1 generic with a $5 to $15 copay. Medicare Part D typically charges $0 to $5. Medicaid copays range from $0 to $3. High-deductible plans require paying the full cash price until the deductible is met.
Is brand-name Glucophage better than generic metformin? No. Generic metformin and Glucophage contain the same active ingredient (metformin hydrochloride) and produce equivalent glycemic control. The FDA requires generics to be bioequivalent to brand-name. Paying extra for Glucophage provides no clinical advantage for most patients.
Why does metformin cost more at CVS than Walmart? Retail pricing strategies differ between chains. Walmart uses metformin as a loss leader in its $4 generic program to drive pharmacy traffic. CVS prices metformin higher but offers frequent coupons. For insured patients, the copay is usually the same regardless of pharmacy.
Does GoodRx work for metformin? Yes. GoodRx coupons reduce metformin's cash price by $3 to $8 at most pharmacies. However, Walmart's $4 generic program is often cheaper than GoodRx. Compare both before filling.
How much does metformin ER cost compared to regular metformin? Generic metformin ER costs $15 to $40 monthly, about $10 to $25 more than immediate-release. The premium is justified if IR causes GI side effects. Brand-name Glucophage XR costs $120 to $180, which is rarely worth paying.
Can I get metformin for free? Publix offers free metformin 500 mg and 850 mg with a prescription (no insurance required). Some patient assistance programs provide free metformin to low-income patients, though metformin is cheap enough that most patients can afford the $4 to $10 cash price.
Why is metformin so cheap? Metformin has been generic since 2002 with no patent protection. Over 15 manufacturers produce it, creating intense price competition. It's also a high-volume medication (92 million prescriptions annually in the U.S.), which drives per-unit costs down.
Does Costco require membership to fill metformin? No. Costco allows non-members to use the pharmacy, though prices are slightly higher than member pricing. Costco's metformin ER pricing is consistently $8 to $15 lower than CVS or Walgreens, making it worth visiting even without membership.
Is metformin covered by Medicare? Yes. Medicare Part D plans cover metformin as a Tier 1 generic with typical copays of $0 to $5. Metformin requires no prior authorization under Medicare.
What if I can't afford metformin? If you can't afford the $4 to $20 monthly cost of metformin, contact your provider about patient assistance programs. The Partnership for Prescription Assistance (pparx.org) connects low-income patients with free medication programs. Most patients qualify for free metformin if household income is below 200% of the federal poverty level.
Should I buy a 90-day supply of metformin to save money? Yes, if your insurance allows it. A 90-day supply costs $10 at Walmart (vs $12 for three 30-day fills). With insurance, a 90-day fill often has a lower total copay than three separate monthly fills. Ask your pharmacy if your plan covers 90-day supplies.
Sources
- Flory JH et al. Metformin prescribing patterns and outcomes in the United States, 2015-2021. Diabetes Care. 2022.
- Karalis V et al. Bioequivalence of generic metformin formulations: comparative dissolution study. Pharmaceutics. 2019.
- Florez JC et al. Metformin gastrointestinal intolerance: incidence and risk factors. Diabetes Care. 2010.
- Gong L et al. Metformin extended-release versus immediate-release: systematic review and meta-analysis. Diabetes Therapy. 2021.
- Blonde L et al. Physician prescribing patterns for branded versus generic metformin. Endocrine Practice. 2018.
- Kirkman MS et al. Primary medication nonadherence in newly diagnosed type 2 diabetes. Diabetes Care. 2020.
- FDA Drug Shortages Database. Metformin hydrochloride extended-release tablets shortage. 2020.
- American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.
- Bailey CJ et al. Metformin: historical overview. Diabetologia. 2017.
- Foretz M et al. Metformin: from mechanisms of action to therapies. Cell Metabolism. 2014.
- Inzucchi SE et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care. 2012.
- Roumie CL et al. Comparative effectiveness of metformin versus sulfonylureas. Annals of Internal Medicine. 2019.
- Crowley MJ et al. Clinical outcomes of metformin use in populations with chronic kidney disease. Diabetes Care. 2017.
- Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin. Diabetes Care. 2012.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Glucophage is a registered trademark of Merck & Co. Walmart, CVS, Costco, Walgreens, Kroger, Publix, Sam's Club, Amazon Pharmacy, GoodRx, and Mark Cuban Cost Plus Drugs are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →